NYSE

Veradermics, Inc

MANE

1 story

$4.8B Market cap · 2026-10-16

Novo Nordisk has only floated hair loss, while Veradermics’ Phase 3 oral minoxidil data lead a field of licensing and takeover candidates.

Cestrian Capital Research 40m ago

Tickers on this page

Companies the stories above are also about, besides MANE.